Salute e Benessere

Thousand Oaks Biologics Showcases Integrated ADC CRDMO Solutions & Media…

Antibody-drug conjugates (ADCs) are a key driver of China's innovative drug globalization. Leveraging its end-to-end CRDMO model and international compliance qualifications, Thousand Oaks Biologics is positioned to address critical industry pain points, including R&D efficiency, scale-up costs, and regulatory risks. Its core competencies encompass a self-sufficient supply of critical raw materials, superior cost-control and efficiency, a rigorous quality management system, and an…
PR Newswire
29/10/2025

StickIt Clarifies Corporate Reorganization Share Consolidation and Proposed…

Although the transactions contemplated by the LOI will result in results in new shareholders holding greater than 50% of the voting securities of the Company, it is not expected to result in change of control of the Company. The transactions contemplated by the LOI are not expected to result in Fundamental Change (as defined in the Canadian Securities Exchange (the "CSE") policies), subject to the discretion of the CSE. Although the transactions contemplated by the LOI will result in…
PR Newswire
29/10/2025

Late-breaking iMODERN findings presented at TCT 2025 and published in the New…

3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major outcomes compared with waiting for follow-upAdditional results from the ILIAS ANOCA study highlight the sustained benefits of physiology-guided assessment and tailored medical therapy for patients with angina and no obstructive coronary arteries Amsterdam, the Netherlands –Royal...
Nasdaq GlobeNewswire
29/10/2025

CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical…

CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics ● Testing to focus on the potential to deliver real-time, AI-powered insights that improve patient outcomes and support continuous learning for surgeons Cambridge, UK – 29 October 2025,CMR Surgical (‘CMR’), the global surgical robotics business, today announces it is an early adopter of NVIDIA IGXThor as it evaluates its integration into the Versius Surgical Robotic System.IGX Thor is...
Nasdaq GlobeNewswire
29/10/2025

PARTNERSHIP OMRON HEALTHCARE UK & STROKE ASSOCIATION: Stroke Association and…

The growing stroke crisis in the UK The growing stroke crisis in the UK Stroke is the leading cause of complex adult disability and the fourth biggest cause of death in the UK. Every day, 240 people wake up to the impact of stroke in the UK. AFib, a common heart rhythm disorder, is a significant risk factor, increasing the likelihood of stroke by up to five times (*1). However, AFib often goes undetected due to a lack of symptoms (*2), making regular monitoring crucial for early intervention...
PR Newswire
29/10/2025

Photocure ASA: Results for the third quarter of 2025

The company continued to execute on its plan to expand blue light cystoscopy (BLC®) use in Q3 2025 with the installation of 14 new Saphira towers in the U.S. — 7 new accounts and 7 blue light tower upgrades. In addition, due to increasing demand, ForTec has acquired and deployed 6 additional BLC towers, bringing the total number of mobile BLC towers to 24. With the increasing momentum provided by ForTec's mobile solution, Photocure had 373 active accounts in the U.S. at the end of the quarter…
PR Newswire
29/10/2025

Smartee and Straumann Announce Strategic Partnerships to Accelerate Innovation…

Florian Kirsch, Executive Vice President, Global Head IDT of Straumann Group, said: "We are proud to join forces with a strong global partner like Smartee. Together we will accelerate innovation in orthodontics and build a platform that makes high-quality, predictable treatment more accessible to doctors and patients worldwide." Florian Kirsch , Executive Vice President, Global Head IDT of Straumann Group, said: "We are proud to join forces with a strong global partner like…
PR Newswire
29/10/2025

Insilico Showcases Advanced Generative Biologics Engine in Breakthrough 72-Hour…

In a recent pioneering study, Insilico has demonstrated the remarkable potential of generative biologics to rapidly design peptides targeting GLP1R—the receptor modulated by blockbuster diabetes drugs such as Ozempic. Leveraging its Biology42: Generative Biologics engine, Insilico's R&D team generated over 5,000 novel peptides within a 72-hour cycle, without referencing any known GLP1R binders. From these, 20 top candidates were selected for synthesis and wet-lab evaluation based on…
PR Newswire
29/10/2025

Addex Increases Issued Share Capital to Create Treasury Shares

Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, October 29, 2025-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN),a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that 34,300,000 new registered shares at a nominal value of CHF 0.01 have been issued and fully subscribed by Addex Pharma S.A, its 100% wholly-owned subsidiary. The new shares, issued from...
Nasdaq GlobeNewswire
29/10/2025

Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag…

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute fever-causing illnesses.Full automation facilitates medium to high throughput and enables improvement of lab efficiency and test traceability, while reducing the risk of human error. Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management...
Nasdaq GlobeNewswire
29/10/2025

Electric Wheelchair Market Surges Toward US$ 19.12 Billion by 2033 -- Driven by…

Browse in-depth TOC on ' Electric Wheelchair Market111 - Tables134 - Figures268 - Pages Browse in-depth TOC on ' Electric Wheelchair Market 111 - Tables 134 - Figures 268 - Pages The global electric wheelchair market is driven by a convergence of demographic shifts, technological leaps, and evolving consumer expectations. No longer simply a means of mobility, the modern electric wheelchair is a sophisticated device that offers unprecedented levels of independence, connectivity, and...
PR Newswire
29/10/2025

VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe

The MOU was signed on October 27 during a local meeting held in conjunction with the 38th Annual Congress of the European Society of Intensive Care Medicine (ESICM LIVES 2025), which took place from October 25 to 29 in Munich, Germany. Through this agreement, the three companies will collaborate on technical integration, real-world validation, and reimbursement strategies to support the adoption of DeepCARS across European hospitals. The MOU was signed onOctober 27during a local meeting...
PR Newswire
29/10/2025

CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM…

Key Takeaways from the CAR T-cell Therapy Market Report Key Takeaways from the CAR T-cell Therapy Market Report Discover which indication is expected to grab the major CAR T-cell therapy market share @CAR T-cell Therapy Market Report Key Factors Driving the CAR T-cell Therapy Market Large and Growing Unmet Need in Oncology Rising cancer incidence, especially relapsed/refractory hematologic malignancies and an expanding focus on solid-tumor settings, creates a sustained...
PR Newswire
28/10/2025

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting®…

Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosisNew Iqirvo® PBC and PSC data to be presented by partner Ipsen, underscoring its potential in rare cholestatic liver diseases Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), October 28, 2025-GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company...
Nasdaq GlobeNewswire
28/10/2025

DBV Technologies Reports Third Quarter 2025 Financial Results

DBV Technologies Reports Third Quarter 2025 Financial Results DBV closes Q3 2025 with a cash and cash equivalents balance of $69.8 million, taking cash runway into the third quarter of 2026DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company (the "Company"), reported financial results for the third quarter of 2025. The quarterly and nine months unaudited financial statements were approved...
Nasdaq GlobeNewswire
28/10/2025

Electronic Toothbrush Market to Reach USD 6,480.86 million by 2032, Growing At…

Browse the report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/electronic-toothbrush-market Browse the report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/electronic-toothbrush-market Market Overview The Electronic Toothbrush Market comprises devices designed to clean teeth using powered bristle movements, offering a more effective and consistent alternative to traditional...
PR Newswire
28/10/2025

Taiwan TCM Pavilion Draws Global Interest at CPHI Frankfurt 2025

Organized by the Department of Chinese Medicine and Pharmacy (DCMP) under Taiwan's Ministry of Health and Welfare (MOHW) and implemented by the Taiwan Institute of Economic Research (TIER), the Pavilion highlights Taiwan's integrated approach to traditional medicine — combining rich clinical heritage, modern scientific validation, and robust regulatory support. Organized by the Department of Chinese Medicine and Pharmacy (DCMP) underTaiwan'sMinistry of Health and Welfare (MOHW) and...
PR Newswire
28/10/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from October 20th to October 24th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1120/10/2025FR0010259150563...
Nasdaq GlobeNewswire
28/10/2025

BASTIDE : 2025-2026 financial calendar

Caissargues, October 28, 2025 Events Dates* 2025-2026 Q1 Revenue Thursday November 13, 2025 2025-2026 H1 Revenue Thursday February 12, 2026 2025-2026 H1 Results Wednesday March 18, 2026 2025-2026 Q3 Revenue Thursday May 14, 2026 2025-2026 Full-Year Revenue Thursday September 3, 2026 2025-2026 Full-Year Results Wednesday October 21, 2026 * Subject…
Actusnews Wire
28/10/2025

ONWARD Medical Publishes Closing of Bookbuild Offering

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)EINDHOVEN, The Netherlands, Oct.28, 2025(GLOBE NEWSWIRE) --...
Nasdaq GlobeNewswire
28/10/2025

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

Key accomplishments from the report include: In 2024, Curia committed to setting near-and long-term company-wide GHG emission reductions in line with climate science through the Science Based Target Initiative (SBTi) and joined the United Nations’ Race to Zero campaign, a global coalition of non-state entities working toward halving global emissions by 2030.Curia’s French facilities in Bon Encontre and Tonneins achieved ISO 9001, 45001 and 14001 certifications, and its sites in Origgio...
Nasdaq GlobeNewswire
28/10/2025

Wound Irrigation System Market to Reach $465.3 million, Globally, by 2034 at…

Request Sample of the Report on Wound Irrigation System Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A43041 Request Sample of the Report on Wound Irrigation System Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A43041 Market Introduction Wound irrigation systems are medical devices designed to deliver a controlled flow of solutions for cleansing wounds, removing debris, and reducing microbial load. They play a critical role...
PR Newswire
28/10/2025

Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR |…

Browse in-depth TOC on "Cell-free Protein Synthesis Market" Browse in-depth TOC on "Cell-free Protein Synthesis Market" 400 - Tables 45 - Figures 300 - Pages By offerings,the cell-free protein synthesis market is divided into products (such as expression systems, reagents, and instruments) and services. CFPS services are expected to grow the fastest in the CFPS market during the forecast period, due to their ability to deliver customized protein expression, lower...
PR Newswire
28/10/2025

Glucagon-Like Peptide-1 Analogues Market to Surpass USD 299.08 Billion by 2033…

Market Dynamics: The Dual Impact of Diabetes and Obesity Epidemics Market Dynamics: The Dual Impact of Diabetes and Obesity Epidemics The GLP-1 analogues market is being reshaped by intersecting public health trends- the global rise in obesityand theincreasing prevalence of type 2 diabetes. According to DataM Intelligence, over1 billion people worldwideare now classified as obese, while diabetes affectsover 540 million adults globally, intensifying the need for multi-target...
PR Newswire
28/10/2025
Altri  Comunicati